Surgical Navigation Systems Market Size, Share & Trends Analysis Report By Application (ENT, Orthopedic, Neurology, Dental), By Technology (Electromagnetic, Optical), By End Use, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global surgical navigation systems market size was valued at USD 6.9 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.2% from 2022 to 2030. The rising prevalence of target disorders such as osteoarthritis, brain cancer, and ENT disorders along with the increasing geriatric population is expected to propel the growth. According to the World Health Organization (WHO), 9.6% of men and 18% of women suffer from various forms of arthritis. Osteoarthritis generally affects the geriatric population. Most osteoarthritis patients have difficulty in movement and are unable to perform daily activities.

Furthermore, the rising demand for minimally invasive surgeries is another factor responsible for escalating the adoption of these devices over the forecast period. Minimally invasive surgeries involve lesser incision wounds leading to quicker recovery time, shortened hospitals stay, and enhanced patient comfort. Moreover, these procedures are economically viable due to the shorter duration of hospital stays. The amount of blood loss during minimally invasive surgeries is lesser than the conventional open surgeries. Technological advancements in these procedures and the introduction of new products are expected to further drive the market.

An unprecedented rise in the population aged 60 years and above is anticipated to increase the demand for hip and knee replacement surgeries. This factor is expected to positively influence market growth. Furthermore, the presence of a supportive regulatory structure is also anticipated to drive the overall growth of the market and the demand for surgical navigation systems. Rising reimbursement coverage for orthopedic procedures, such as knee replacement is expected to fuel the adoption of these systems by the surgeons in near future.

Facing the outbreak of COVID-19, the medical setting across the globe has changed dramatically, offering unprecedented challenges to routine clinical practice. Owing to restrictions on elective procedures, the pandemic has significantly impacted the surgical navigation system market. As restrictions resulted in delays to a number of procedures. There was a 25–75% reduction in elective surgery in Japan. However, other factors, such as the demand for better patient outcomes will drive the uptake of novel technologies in navigation-assisted surgeries and support market growth. For instance, in February 2021, Royal Philips announced the introduction of ClarifEye Augmented Reality Surgical Navigation for minimally invasive spine procedures 

Application Insights 

The neurology segment held the largest revenue share of 37.0% in 2021 as it was the first surgical branch to implement navigation and integrate it successfully into the clinical routine. Neurology involves the treatment of brain cancer and various disorders of the Central Nervous System (CNS) that demand precise diagnosis and accurate procedures, possible with the aid of SNSs. An upsurge in the number of individuals suffering from brain tumors and cancer leading to brain metastasis is likely to boost demand for neuro-navigation systems.

Navigation offers accurate localization of vital anatomic structures, such as cranial nerves or carotid artery, particularly if they are deep in the tumor. Furthermore, it provides a real-time display of a tracked instrument thereby providing increased anatomic appreciation and enhancing the confidence of surgeons and their perception of safety. The aforementioned benefits are expected to contribute towards a steady growth of this segment. The Ear, Nose, and Throat (ENT) surgery segment is expected to grow lucratively over the forecast period, owing to the rising prevalence of ENT disorders.

Primary advantages offered by SNSs in ENT surgeries include greater precision resulting in lower risk to the patient, reduced discomfort, reduced invasiveness, and shorter recovery time. Most individuals experience an ear, nose, or throat problem from time to time. One in four Americans over age 65 suffers disabling hearing loss. Head and neck cancer denote different malignant tumors in or around the throat, larynx, nose sinuses, and mouth. Every year it affects over 63,000 people in the U.S. An estimated 2.4 million eye injuries occur in the U.S. per annum. These factors highlight the potential demand for ENT surgical navigation systems, thereby boosting the overall market growth. 

End-user Insights 

The hospitals segment held the largest revenue share of the market in 2021 and is anticipated to continue leading the market over the forecast period. Technologically advanced medical devices are being used extensively used in hospitals to improve Point-of-Care (PoC). These devices not only simplify the treatment procedures but also enable faster and more accurate results. Hospitals also provide a large array of treatment options pertaining to pain management and orthopedic procedures. Owing to these factors the segment is expected to continue witnessing steady growth in the near future.

The Ambulatory Surgical Centers (ASC) segment is expected to witness exponential growth over the forecast period. High adoption of ASCs in developed countries, shortage of hospital beds, and scarce economic resources are the factors expected to boost the growth. Advantages of day-care surgery include a shorter waiting list, quick discharge, reduced procedural cost, and higher efficiency. These factors are expected to further fuel growth.

Technology Insights

The Electromagnetic (EM) segment dominated the surgical navigation systems market and held the largest revenue share of 42.0% in 2021. This growth is attributed to the ease of use, better line of sight, and affordability of the technology as compared to optical navigation. These systems were introduced even before the optical and hybrid SNSs and hence, they have a penetration rate. The segment is anticipated to continue holding the dominant market share in the forthcoming years. In August 2020, joimax, a Germany-based firm announced that its electromagnetic navigation tracking and control system “Intracs” has been approved by the FDA. Hence, supports overall segment growth.

The optical segment is expected to witness exponential growth over the forecast period. Optical SNSs provide better results as compared to electromagnetic surgical navigation systems. They are considered the industry standard for neurosurgeries and are capable of tracking a large number of tools simultaneously. These systems find application in medical procedures, which require very high precision and demand major access paths, such as operations on the lateral skull base. They are unaffected by the presence of metallic objects and electromagnetic fields in the surrounding environment. Such advantages associated with the technology can be attributed to segment growth.

Regional Insights

North America accounted for the largest revenue share of around 41.0% in 2021. The rising prevalence of orthopedic, ENT, and neurological disorders is expected to drive regional growth. A rise in the number of patients consequently increases the demand for surgical navigation systems, thereby boosting the regional demand for surgical navigation systems. Rising preference for ambulatory surgery centers and along with growing procedure volumes, imposing a burden on procedure volumes at hospitals is the primary growth factor. A quality-driven healthcare model coupled with a shifting focus to ambulatory surgeries in a cost-curbing environment is driving the regional demand. In addition, factors such as the increasing geriatric population and well-developed reimbursement structure, contributing to the overall revenue are responsible for the overall development of the regional market.

In Asia Pacific, the market is expected to witness exponential growth over the forecast period. The highest growth rate of the regional market can be attributed to developing economies, an increasing aging population, and growing healthcare awareness. The geriatric population is more susceptible to orthopedic disorders thereby presenting a huge target population in the region, with Japan, China, and India being the major regional contributors. In addition, high-untapped opportunities, rising interest of companies to expand their presence in this region, and continuous R&D activities by the key market players for better innovative products are expected to fuel the growth. For instance, In April 2018, B. Braun opened five new production facilities in Malaysia in an attempt to increase the production of pharmaceutical solutions, medical devices for infusion therapy, and surgical instruments.

Key Companies & Market Share Insights

The market is witnessing intense competition as very few players hold a significant market share, owing to their extensive product portfolio and regional presence. The key players are involved in various strategies such as new product developments, distribution agreements, and expansion strategies to improve their market penetration. For instance, in November 2020, Stryker completed the acquisition of Wright Medical, in an attempt to enhance its global market position in trauma and extremities, providing significant opportunities to improve outcomes, advance innovation, and increase patient reach.

In addition to this, in September 2019, Johnson & Johnson's DePuy Synthes successfully signed an agreement with JointPoint, Inc. According to this agreement, DePuy Synthes acquired the latter's navigation software, which would allow surgeons to improve surgical outcomes in hip arthroplasties. As a result of such initiatives, competitive rivalry in this industry is anticipated to be high in the forthcoming years. Some of the prominent players in the surgical navigation systems market include:

• B. Braun Melsungen AG

• Stryker

• Medtronic

• Corin

• Siemens Healthineers

• Smith+Nephew

• Johnson & Johnson Services, Inc. (DePuy Synthes)

• Zimmer Biomet

• KARL STORZ SE & Co. KG

• Amplitude Surgical

Surgical Navigation Systems Market Report Scope

Segments Covered in the Report 

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global surgical navigation systems market report based on application, technology, end use, and region:

• Application Outlook (Revenue, USD Million, 2017 - 2030)

  • ENT

  • Orthopedic

  • Neurology

  • Dental

  • Others

• Technology Outlook (Revenue, USD Million, 2017 - 2030)

  • Electromagnetic

  • Optical

  • Others

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Hospitals

  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia